On the other hand, there is evidence that LPS infusion mediates the development of obesity, increasing the amount of adipose tissue and glucose intolerance via activation of TLR4 in adipocytes.35 This evidence suggests that changes in LPS levels could be associated with changes in fat mass and VO2 consumption. This evidence concerns the gene TLR4 and obesity due to melanocortin 4 receptor deficiency.